The role of LOXL2 in fibrotic diseases is further supported by a study of Chien and co-workers, in which a positive correlation of LOXL2 serum levels with disease severity and progression was described in IPF patients20. The gene discussed is LOXL2; the disease is idiopathic pulmonary fibrosis.